Q1 2024 · 13F-HR
Alphabet Inc. (GOOG, GOOGL)holdings as filed
Filed 2024-05-03 · accession 0001652044-24-000057
$2.51B
Reported value
43
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 37637K108 | GTLB | GITLAB INC | $569.1M | 22.6% | 9,758,333 | Common | SHARED |
| 22788C105 | CRWD | CROWDSTRIKE HLDGS INC | $274.4M | 10.9% | 855,789 | Common | SHARED |
| 252131107 | DXCM | DEXCOM INC | $248.4M | 9.88% | 1,790,773 | Common | SHARED |
| 042068205 | ARM | ARM HOLDINGS PLC | $245.1M | 9.75% | 1,960,784 | Common | SHARED |
| 358054104 | FRSH | FRESHWORKS INC | $224.7M | 8.94% | 12,336,643 | Common | SHARED |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $170.9M | 6.80% | 5,301,512 | Common | SHARED |
| 92539P101 | — | VERVE THERAPEUTICS INC | $164.0M | 6.52% | 12,349,086 | Common | SHARED |
| 90364P105 | PATH | UIPATH INC | $159.5M | 6.34% | 7,034,337 | Common | SHARED |
| 74168J101 | PRME | PRIME MEDICINE INC | $105.4M | 4.19% | 15,062,498 | Common | SHARED |
| 833445109 | SNOW | SNOWFLAKE INC | $86.6M | 3.44% | 535,604 | Common | SHARED |
| 72703X106 | PL | PLANET LABS PBC | $81.5M | 3.24% | 31,942,641 | Common | SHARED |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $28.1M | 1.12% | 2,812,500 | Common | SHARED |
| 00534A102 | IVVD | INVIVYD INC | $20.1M | 0.80% | 4,527,122 | Common | SHARED |
| 55083R104 | — | LYELL IMMUNOPHARMA INC | $13.1M | 0.52% | 5,865,125 | Common | SHARED |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $13.0M | 0.52% | 1,568,753 | Common | SHARED |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $10.6M | 0.42% | 321,604 | Common | SHARED |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $10.4M | 0.41% | 241,264 | Common | SHARED |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $10.3M | 0.41% | 1,464,015 | Common | SHARED |
| 25058X105 | — | DESKTOP METAL INC | $9.7M | 0.39% | 11,048,730 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $8.6M | 0.34% | 1,077,080 | Common | SHARED |
| 452327109 | ILMN | ILLUMINA INC | $7.3M | 0.29% | 53,470 | Common | SHARED |
| 687793109 | OSCR | OSCAR HEALTH INC | $7.2M | 0.29% | 481,988 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $6.3M | 0.25% | 208,697 | Common | SHARED |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $4.9M | 0.20% | 662,584 | Common | SHARED |
| 75382E109 | — | RAPT THERAPEUTICS INC | $4.9M | 0.19% | 540,270 | Common | SHARED |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $4.8M | 0.19% | 915,705 | Common | SHARED |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $4.5M | 0.18% | 698,262 | Common | SHARED |
| 91864C107 | BRNS | BARINTHUS BIOTHERAPEUTICS PL | $3.6M | 0.14% | 1,513,644 | Common | SHARED |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $3.4M | 0.13% | 500,901 | Common | SHARED |
| 082490103 | — | BENSON HILL INC | $3.1M | 0.12% | 15,352,271 | Common | SHARED |
| 50107A104 | KRON1USD | KRONOS BIO INC | $1.9M | 0.07% | 1,438,232 | Common | SHARED |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $1.8M | 0.07% | 640,882 | Common | SHARED |
| 30063P105 | EXK | EXACT SCIENCES CORP | $1.6M | 0.06% | 23,205 | Common | SHARED |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $1.5M | 0.06% | 889,979 | Common | SHARED |
| 753018100 | RANI | RANI THERAPEUTICS HLDGS INC | $1.4M | 0.06% | 448,492 | Common | SHARED |
| 014442107 | ALEC | ALECTOR INC | $1.1M | 0.04% | 175,866 | Common | SHARED |
| 44916K106 | HYPR | HYPERFINE INC | $898,720 | 0.04% | 898,720 | Common | SHARED |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $200,469 | 0.01% | 189,122 | Common | SHARED |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $134,633 | 0.01% | 14,262 | Common | SHARED |
| 759916109 | RGEN | REPLIGEN CORP | $70,441 | 0.00% | 383 | Common | SHARED |
| 465712107 | MOND | MONDEE HOLDINGS INC | $42,550 | 0.00% | 18,420 | Common | SHARED |
| 229790100 | HLTHQ | CUE HEALTH INC | $5,130 | 0.00% | 27,000 | Common | SHARED |
| 46185L103 | NVTA1EUR | INVITAE CORP | $0 | — | 235,606 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.